DIA Europe 2022 - Launching our New PV Services

DIA EUROPE 2022 Live & Hybrid is Coming Soon, the dates are March 29-31, 2022

iVigee will be exhibiting our previously launched plus our exclusive NEW Services on this occasion.

We would be happy to introduce you to what we have to benefit pharma, biotech and life-science organizations this year. We are confident that overall global patient safety will be excited with what we are ready to launch.

Feel free to reach out to us in advance to schedule meeting time.

Four members of our founding team at iVigee will be present including: Dr. Jan Petracek, Dr. Marcela Fialova, Robert Scheiner, and Adam Scheuer.

Beyond our services, there will be a wide range of topics discussed in break-out sessions at this year's annual meeting.

Topics include:

• Risk Management Through the Product Lifecycle 2013 From Strategy to Implementation
  Chaired by Almath Spooner from Abbvie
• Case Studies for AI-Based Intelligent Automation in Pharmacovigilance
  Chaired by Neal Grabowski, AbbVie, U.S.A.
• Getting 80% of Safety Work Done at the Ingestion Step
  Chaired by Updesh Dosanjh, IQVIA, U.S.A
• Assessing Exposures to Medicines During Pregnancy: An Evolving Landscape
  Chaired by Lisa Prach, Novartis, Switzerland, with speakers such as Bita Rezaallah, Novartis, Switzerland, Viola Macolic Sarinic, European Medicines Agency, The Netherlands and Marianne Cunnington, GlaxoSmithKline, United Kingdom
• Tipping the Balance 2019 2019 2013 The Level of Technology vs Human Intervention Deployed in the Identification of Safety Risk in Data Sources
  Chaired and presenting is Alison Sloane, IQVIA, Ireland
• Transforming Pharmacovigilance at the MHRA
  Chaired by Alison Cave, Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom with speakers: Mick Foy, Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom and Phil Tregunno, Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
• Pharmacovigilance Inspections
  Chaired by Raphael Van Eemeren, Amgen AB, Sweden with several currently unannounced speakers.

We look forward to meeting you, and finding new ways we can help your organization achieve your drug safety and pharmacovigilance goals for 2022 and beyond.

For more details from this DIA event, DIA's dedicated webpage can help - click here.

To contact our team prior to the event, feel free to visit our contact page.